secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silexion Therapeutics Corp (SLXN)
CIK:        0002022416
Form:       8-K
Filed at:   2025-07-14T23:59:59+00:00
Accession:  0001178913-25-002378
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Silexion shareholders approve 1-for-15 reverse split and board election
-----------------------------------------------------------------------

- Reverse share split at 1-for-15 ratio approved with 59.6% of votes in favor.
- Equity incentive plan shares increased by 1,271,859 to 1,428,268 total.
- All seven director nominees elected; Ruth Alon (68.2%) and Ilan Levin (68.1%) received lowest support.
- Ratification of Kesselman & Kesselman (PwC) as auditors approved with 98.3% in favor.
- Meeting reconvened after July 7 adjournment due to lack of quorum; 12.1% of shares represented.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2022416/000117891325002378/0001178913-25-002378-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2022416/000117891325002378/zk2533438.htm
  HTML page:      https://secwatch.observer/filing/0001178913-25-002378

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer